Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-01

FDA Approved: MUCUS RELIEF DM — Original Application (Dolgencorp, Inc. (DOLLAR GENERAL & REXALL))

View source ↗

Summary

FDA approved the original application for MUCUS RELIEF DM, a combination cough suppressant and expectorant (guaifenesin and dextromethorphan HBr) from Dolgencor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MUCUS RELIEF DM (guaifenesin; dextromethorphan HBr)

Snippet

ORIG AP for MUCUS RELIEF DM (GUAIFENESIN, DEXTROMETHORPHAN HBR)